NCT06794710View on ClinicalTrials.gov

Early Identification and Treatment of Rare Cardiomyopathy Cohorts

NANot yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

May 30, 2027

Study Completion Date

September 30, 2027

Conditions
Hypertrophic Cardiomyopathy (HCM)Dilated Cardiomyopathy (DCM)Metabolic CardiomyopathyRestrictive Cardiomyopathy
Interventions
DRUG

diuretics, ACEIs/ARBs, beta blockers, positive inotropic drugs, MRAs, SGLT2i, retinoids

Patients in this group will receive pharmacological treatment for heart failure.

BEHAVIORAL

Close follow-up

High risk patients receive close follow-up

BEHAVIORAL

early rehabilitation guidance

Early rehabilitation guidance such as cardiopulmonary exercise tests and cardiac rehabilitation therapy

Trial Locations (1)

200030

Renji Hospital, Shanghai

All Listed Sponsors
lead

RenJi Hospital

OTHER

NCT06794710 - Early Identification and Treatment of Rare Cardiomyopathy Cohorts | Biotech Hunter | Biotech Hunter